Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
Diabetologia|March 26, 2003
The role of oral antidiabetic agents: why and when to use an early-phase insulin secretion agent in Type II diabetes mellitusE Standl, M FüchtenbuschMMW Fortschritte Der Medizin|June 30, 2006
[Diabetes mellitus--differential diagnosis]M Hummel, M FüchtenbuschExperimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|August 5, 2000
Clinical efficacy of new thiazolidinediones and glinides in the treatment of type 2 diabetes mellitusM Füchtenbusch, E Standl, H SchatzMMW Fortschritte Der Medizin|October 9, 2007
[Diabetes mellitus and heart failure]M Füchtenbusch, E Standl, W Otter, et al.Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|March 22, 2005
Transfer of diabetes from prediabetic NOD mice to NOD-SCID/SCID mice: association with pancreatic insulin contentM Füchtenbusch, E Larger, K Thebault, et al.Journal of Autoimmunity|January 5, 2002
No evidence for an association of coxsackie virus infections during pregnancy and early childhood with development of islet autoantibodies in offspring of mothers or fathers with type 1 diabetesM Füchtenbusch, A Irnstetter, G Jäger, et al.Diabetes Care|July 15, 2000
No major association of breast-feeding, vaccinations, and childhood viral diseases with early islet autoimmunity in the German BABYDIAB StudyM Hummel, M Füchtenbusch, M Schenker, et al.Diabetes, Obesity & Metabolism|March 7, 2001
Effect of acarbose on additional insulin therapy in type 2 diabetic patients with late failure of sulphonylurea therapyE Standl, H J Baumgartl, M Füchtenbusch, et al.Diabetes|September 1, 1997
Prediction of type 1 diabetes postpartum in patients with gestational diabetes mellitus by combined islet cell autoantibody screening: a prospective multicenter studyM Füchtenbusch, K Ferber, E Standl, et al.Pageof 3